European Archives of Psychiatry and Clinical Neuroscience

, Volume 251, Supplement 1, pp I31–I34

The pharmacological treatment of catatonia: an overview

  • Gabor S. Ungvari
  • Leung Siu Kau
  • Tang Wai-Kwong
  • Ng Fung Shing
Article

DOI: 10.1007/PL00014198

Cite this article as:
Ungvari, G., Kau, L., Wai-Kwong, T. et al. European Archives of Psychiatry and Clinical Neurosciences (2001) 251: I31. doi:10.1007/PL00014198

Abstract

Over the past two decades, catatonia, particularly its acutely emerging akinetic-hypokinetic (stuporous) variant, has gradually regained its importance in descriptive psychopathology. Electroconvulsive therapy and lately benzodiazepines are not only effective treatment options in this form of catatonia, but also helped generate neurobiological hypotheses concerning its pathophysiology. Within this broad framework, this paper summarizes the results of recent benzodiazepine treatment response studies in catatonic movement disorders with particular reference to the authors' own studies in Chinese patients with catatonia.

Key words CatatoniaTreatmentBenzodiazepinesElectroconvulsive therapy

Copyright information

© Steinkopff Verlag 2001

Authors and Affiliations

  • Gabor S. Ungvari
    • 1
  • Leung Siu Kau
    • 2
  • Tang Wai-Kwong
    • 1
  • Ng Fung Shing
    • 2
  1. 1.Department of Psychiatry, Prince of Wales Hospital, Shatin, N.T., Hong Kong SAR, China, E-mail: gsungvari@cuhk.edu.hkCN
  2. 2.Castle Peak Hospital, Hong Kong SAR, ChinaCN